Related Experiment Video
Updated: Jun 3, 2026
07:13
Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation
Erin E Matthews1, Damien Thévenin, Julia M Rogers
1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8114, USA.
Summary
Rotational movements in the thrombopoietin receptor (TpoR) transmembrane helices dictate its activity states. Small molecules activate TpoR by binding to these helices and utilizing rotational states.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The thrombopoietin receptor (TpoR) is a type 1 cytokine receptor crucial for regulating blood platelet production.
- Understanding TpoR activation mechanisms is vital for developing targeted therapies.
Purpose of the Study:
- To elucidate the role of transmembrane (TM) helix interactions in TpoR activity states.
- To investigate the mechanism of action for small-molecule agonists that do not mimic the natural ligand.
Main Methods:
- Cysteine cross-linking
- Alanine-scanning mutagenesis
- Computational simulations
- In vitro and cellular assays
Main Results:
- TpoR TM dimerizes strongly and adopts three stable, rotationally distinct conformations.
- These conformations likely correspond to active, inactive, and partially active receptor states.
- Small-molecule agonists activate TpoR via a novel allosteric mechanism involving TM helix rotations.
Conclusions:
- Receptor subunit rotations, not monomer-dimer transitions, link TpoR signaling and inactive states.
- TM domain rotations are integral to cytokine receptor activation.
- Small molecules can exploit these rotational states for TpoR activation.
Related Concept Videos
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...